Metformin and the Microbiome

Dr. Judy Magalhaes
May 1
2 min read

Metformin has been a staple in the treatment of type 2 diabetes (T2D), however research over the past decade has shown that the benefits of metformin go further than blood sugar control.

Growing evidence suggests that metformin exerts part of its therapeutic effect by changing the gut microbiome, an ecosystem of trillions of bacteria crucial to digestion, immunity, and metabolic health.

How Metformin Reshapes the Gut Microbiome

Metformin causes noticeable shifts in the composition of gut bacteria, especially in people with type 2 diabetes.

Akkermansia muciniphila (akker·man·si·a+·muciniphi·la)

One of the most consistent findings across studies is an increase in Akkermansia muciniphila, a beneficial bacterium known for its role in strengthening the gut barrier and reducing systemic inflammation.

The presence of Akkermansia muciniphila is often linked with improved insulin sensitivity and metabolic markers.

Escherichia (eh·shr·i·kee·uh)

Another notable change is the rise in Escherichia species. While some strains of E. coli may assist in carbohydrate metabolism, an overabundance can lead to gastrointestinal side effects like bloating and diarrhea which are common complaints among new metformin users.

_________________

Key Microbial Changes:

⬆️ Akkermansia muciniphila — linked to reduced inflammation
⬆️ Escherichia spp. — potential metabolic aid but also a GI disruptor
Altered Firmicutes/Bacteroidetes ratio — a pillar of metabolic modulation

Boosting Metabolic Health via Microbial Metabolites

Metformin changes which bacteria are in your gut and also what they produce.

It enhances the generation of short-chain fatty acids (SCFAs) like butyrate, acetate, and propionate.

Short-chain fatty acids are powerful anti-inflammatory agents and play a direct role in improving insulin sensitivity, gut barrier function, and energy metabolism.

However, these benefits may be time-sensitive. One study found that short-chain fatty acids levels were elevated after six months of metformin treatment but had diminished by the twelve-month mark, suggesting the microbiome’s response may adapt or plateau over time.

_________________

SCFA-Related Benefits:

Butyrate: Fuels colonocytes, reduces inflammation
Acetate: Supports lipid metabolism
Propionate: Modulates glucose production

Metformin, Microbes and You

Metformin’s effects on the gut microbiome aren’t the same for everyone.

Genetics, diet, dosage, and how long you’ve been taking it all play a role in how your microbiome responds.

For some, the changes may boost metformin’s benefits, improving insulin sensitivity and reducing inflammation. For others, the same shifts could lead to side effects or reduced results.

This variation shows the promise of personalized medicine. In the future, we may use individual microbiome profiles to guide metformin use or even pair it with targeted probiotics or prebiotics for better outcomes.

As science uncovers more about these microbial connections, we move closer to therapies that work with your body’s ecosystem and not against it.